Patents by Inventor Ute Jaeger

Ute Jaeger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Generation and Profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38
    Patent number: 8486394
    Abstract: The present invention provides novel antibodies and functional fragments thereof specific for CD38, and methods of using the same for the treatment of diseases associated with CD38 expression, including hematological malignancies such as multiple myeloma.
    Type: Grant
    Filed: November 8, 2011
    Date of Patent: July 16, 2013
    Assignee: Morphosys AG
    Inventors: Michael Tesar, Ute Jäger
  • GENERATION AND PROFILING OF FULLY HUMAN HUCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38
    Publication number: 20120052078
    Abstract: The present invention provides novel antibodies and functional fragments thereof specific for CD38, and methods of using the same for the treatment of diseases associated with CD38 expression, including hematological malignancies such as multiple myeloma.
    Type: Application
    Filed: November 8, 2011
    Publication date: March 1, 2012
    Inventors: Michael Tesar, Ute Jäger
  • COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
    Publication number: 20120034231
    Abstract: The present invention relates to antibodies that specifically bind to IL12R?1, the non-signal transducing chain of the heterodimeric IL12 receptor (together with IL12R?2 chain) as well as IL23 receptor (together with IL23R? chain). The invention more specifically relates to specific antibodies that are IL12 and IL23 receptor antagonists capable of inhibiting IL12/IL18 induced IFN? production of T cells and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by inhibiting IFN? production, such as rheumatoid arthritis, psoriasis or inflammatory bowel diseases or other autoimmune and inflammatory disorders.
    Type: Application
    Filed: March 29, 2010
    Publication date: February 9, 2012
    Applicant: NOVARTIS AG
    Inventors: Michael Bardroff, José M. Carballido Herrera, Daniela Della Ducata, Christoph Heusser, Ute Jaeger, Christoph Schwaerzler
  • Generation and profiling of fully human gold-derived therapeutic antibodies specific for human CD38
    Patent number: 8088896
    Abstract: The present invention provides novel antibodies and functional fragments thereof specific for CD38, and methods for using the same. These antibodies as well as the novel methods for using those antibodies can be used to treat, for example, hematological malignancies such as multiple myeloma.
    Type: Grant
    Filed: October 12, 2006
    Date of Patent: January 3, 2012
    Assignee: Morphosys AG
    Inventors: Michael Tesar, Ute Jäger